CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 60 enrolled
Drug / intervention
Oral Glutathione +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03020719
NCT03020719Phase 2Completed
CompareCT.gov

A Multi Center Placebo Controlled Double Blind Randomized Study Evaluating the Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis

University of Minnesota·interventional·Posted Jan 13, 2017·Updated Jan 9, 2020

In Brief

A Phase 2 clinical trial evaluating Oral Glutathione and Placebo for Cystic Fibrosis. Completed, enrolled 60 participants across 18 sites.

Detailed Summary

The purpose of this randomized, placebo-controlled (Phase II) study will be to further evaluate the effects of oral glutathione on growth in children with CF.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCystic Fibrosis
CountriesUnited States
CollaboratorsCystic Fibrosis Foundation

Timeline

Phase 2CompletedFinished
2017201820192020202120222023202420252026
First PostedJan 13, 2017
Enrollment StartJun 14, 2017
Primary CompletionDec 12, 2018
TodayJul 2, 2026
Enrollment to primary: 1.5 yearsPosted 9.5 years ago

Interventions

Oral Glutathionedrug

Oral Glutathione oral powder

Placebodrug

Placebo oral powder